Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06902480 | NOT YET RECRUITING | Post-menopausal Women

Dairy Choline Bioavailability
Sponsor:

University of Wisconsin, Madison

Brief Summary:

The goal of this clinical trial is to find out if dairy is a good source of choline compared to eggs. The main questions it aims to answer are: * How the body uses choline; and, * What effect WPPC has on choline metabolism. Researchers will compare Whey Protein Phospholipid Concentrate (WPPC) to whole egg powder to see if WPPC is as effective as eggs. Participants will drink a chocolate-flavored drink mixed with either WPPC or whole egg powder.

Condition or disease

Post-menopausal Women

Post-menopausal Status

Intervention/treatment

WPPC

Whole egg powder

Phase

NA

Detailed Description:

This study is intended to evaluate the bioavailability and metabolism of choline in WPPC compared to the most commonly -used food for bioavailable choline, whole egg. The intent of the evaluation is to improve the knowledge of how WPPC contributes to the nutritional needs and health of postmenopausal women.

Study Type : INTERVENTIONAL
Estimated Enrollment : 24 participants
Masking : SINGLE
Primary Purpose : OTHER
Official Title : Assessing Choline Bioavailability and Metabolism from a New Dairy Ingredient for Post-Menopausal Women
Actual Study Start Date : 2025-05
Estimated Primary Completion Date : 2026-08
Estimated Study Completion Date : 2026-08

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 51 Years to 70 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Ages between 51 and 70
  • * Is currently post-menopausal (Post-menopausal is a term used to describe the time in a woman's life after she has gone through menopause. This usually happens between the ages of 45 and 55. Menopause is when a woman's menstrual periods stop permanently (at least 12 months))
  • * Not allergic to the intervention foods and allergens that are related to the production of intervention foods (e.g. dairy products, egg, fish, peanut, shellfish, soy, tree nuts, wheat, crustaceans, gluten, mollusks, mustard, sesame seeds.)
  • * Had stable body weight (± 5%) for the past 6 months
  • * Free from cancer
  • * Did not have weight loss surgery, colon surgery
  • * Do not have chronic kidney diseases
  • * Do not have malabsorption towards fat and dairy products
  • * Willing to complete health surveys
  • * Willing to complete two 4-day food records
  • * Willing to consume the chocolate-flavored intervention beverages
  • * Willing to provide blood, urine, fecal samples at baseline and after 10 days of intervention
Exclusion Criteria
  • * On weight loss/weight gain diets
  • * Diagnosed with fat malabsorption
  • * Undergoing weight loss surgery
  • * Diagnosed with chronic kidney diseases
  • * Allergic to the intervention foods and allergens that are related to the production of intervention foods (e.g. dairy products, egg, fish, peanut, shellfish, soy, tree nuts, wheat, crustaceans, gluten, mollusks, mustard, sesame seeds.)
  • * Regularly using antibiotics or probiotics or prebiotics
  • * Regularly using Orlistat or Cetilistat
  • * Regularly using laxatives
  • * Undergoing hormone replacement therapy, or receiving hormones in any forms
  • * Unable to avoid strenuous exercise during the study (\>4 h intense exercise per day)
Dairy Choline Bioavailability

Location Details

NCT06902480

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Wisconsin

University of Wisconsin - Madison

Madison, Wisconsin, United States, 53705